Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors

dc.contributor.authorHopf, Frederic W.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2022-05-10T14:01:37Z
dc.date.available2022-05-10T14:01:37Z
dc.date.issued2020-05-15
dc.description.abstractThe neuropeptide hypocretin/orexin plays a broad and important role in physiological functions ranging from addiction, stress, and anxiety to sleep, energy metabolism, and homeostatic regulation. A number of recent reviews addressing the importance of orexin for different addictive behaviors, especially the contribution of orexin-1-receptors (Ox1Rs) in responding for intoxicants in higher-motivation individuals and situations, and orexin-2-receptor (Ox2Rs) in stress-related aspects of addictive responding. This may parallel the importance of more lateral orexin neurons in the hypothalamus for reward and more medial for stress and arousal. However, there is clearly also some crossover, which may reflect, in part, where positive and negative conditioning (reward- and relief-seeking) are both present concurrently in established addiction, and also where orexin signaling can differ in subregions of a particular brain region. Here, we attempt to examine and synthesize some of the most recent work addressing orexin functions in addiction, including a particular role for Ox1Rs for driving responding in higher-motivation individuals and under higher levels of effort. While there are some commonalities across addictive substances addressed here (alcohol, cocaine, opiates), there are also some differences, which may relate to several factors including the speed of intoxication with a given substance. Together, recent findings have shed important insight and clues into what a more unified role of Ox1Rs might entail, and critical areas for future work. In addition, these many studies support the development of Ox1R blockers for use in humans to counteract addiction and other disorders of motivation. This article is part of the special issue on Neuropeptides.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationHopf, F. W. (2020). Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors. Neuropharmacology, 168, 108013. https://doi.org/10.1016/j.neuropharm.2020.108013en_US
dc.identifier.issn1873-7064en_US
dc.identifier.urihttps://hdl.handle.net/1805/28905
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.neuropharm.2020.108013en_US
dc.relation.journalNeuropharmacologyen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectAddictionen_US
dc.subjectAlcohol Drinkingen_US
dc.subjectOrexin Receptorsen_US
dc.titleRecent perspectives on orexin/hypocretin promotion of addiction-related behaviorsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Hopf2020Recent-AAM.pdf
Size:
414.4 KB
Format:
Adobe Portable Document Format
Description:
Author's Manuscript
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: